Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
04/2002
04/11/2002US20020042377 Rotamase enzyme activity inhibitors
04/11/2002DE10051395A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines
04/11/2002DE10047118A1 Verfahren zur Herstellung von Ketocarbonsäurederivaten Process for the preparation of ketocarboxylic acid derivatives
04/11/2002DE10047111A1 Verfahren zur Herstellung von DELTA·1·-Pyrrolinen A process for preparing DELTA · 1 · -Pyrrolinen
04/11/2002DE10047109A1 Verfahren zur Herstellung von DELTA·1·-Pyrrolinen A process for preparing DELTA · 1 · -Pyrrolinen
04/11/2002DE10046993A1 Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament Substituted Zimtsäureguanidide, processes for their preparation, their use as a medicament and they drug-containing
04/11/2002CA2424684A1 Nitroso diphenylamine derivatives
04/11/2002CA2424116A1 Antitumor therapy comprising distamycin derivatives
04/11/2002CA2419777A1 Pharmaceutical compounds
04/10/2002EP1195376A1 Azoamidine compounds and their use as polymerization initiators
04/10/2002EP0882124B1 Cleaning process and composition
04/10/2002EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom
04/10/2002CN1344248A Method for acylating peptides and novel acylating agents
04/09/2002US6369237 DNA glycosylase inhibitors, and uses related thereto
04/09/2002US6369229 Pyridylalanine derivatives
04/09/2002US6369228 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
04/09/2002US6369194 Alpha-beta-diketo compounds produced by reacting an alpha-keto acid or acid chloride with a ylide such as (cyanomethylene)phosphoranes, oxidizing the cyano diketo phoshorane and reacting with a nucleophile
04/09/2002US6369124 Polymerization processes using aliphatic maleimides
04/09/2002US6369096 Benzyloxy prodigiosine compounds
04/09/2002US6369077 Protease inhibitors
04/09/2002US6368814 Tricyclic antidepressants and metabolites thereof
04/09/2002US6368608 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
04/09/2002CA2095338C Individual stereoisomers of 7-¬3-(aminoalkyl)-1-pyrrolidinyl|-quinolonesand naphthyridones as antibacterial agents
04/04/2002WO2002026750A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
04/04/2002WO2002026711A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
04/04/2002WO2002026706A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
04/04/2002WO2002026705A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
04/04/2002WO2002026697A2 Aromatic derivatives with hiv integrase inhibitory properties
04/04/2002WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
04/04/2002WO2002004407A3 7-substituted tetracycline compounds
04/04/2002WO2002002521A3 Aroyl aminoacyl pyrrole compounds and their pharmaceutical use
04/04/2002WO2001090097A3 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
04/04/2002WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists
04/04/2002US20020040162 Contrast media for angiography
04/04/2002US20020040149 EP4 receptor selective agonists in the treatment of osteoporosis
04/04/2002US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction
04/04/2002US20020040061 Compounds such as 1-(3-(2-hydroxybenzoylamino)propyl)-2-pyrrolidinone; dosage forms of bioactive agents or drugs
04/04/2002US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators
04/04/2002US20020040029 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
04/04/2002US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity
04/04/2002US20020040017 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
04/04/2002US20020040016 Derivatives of azetidine and pyrrolidine
04/03/2002EP1193256A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
04/03/2002EP1193254A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same
04/03/2002EP1193253A1 Process for producing optically active azetidine-2-carboxylic acids
04/03/2002EP1192189A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
04/03/2002EP1192145A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
04/03/2002EP1192140A1 Substituted herbicidal phenyluracils
04/03/2002EP1192136A2 Oligomers and polymers of cyclic imino carboxylic acids
04/03/2002EP1192132A2 Serine protease inhibitors
04/03/2002EP1192129A2 Pharmaceutical compounds
04/03/2002EP1192126A1 C-2 hydroxyl protected-n-acyl(2r,3s)-3-phenylisoserine activated esters and methods for production thereof
04/03/2002EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
04/03/2002EP1158980A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
04/03/2002EP1156807A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
04/03/2002EP1140087A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
04/03/2002CN1343217A New amidinobenzylamine derivatives and their use as thrombin inhibitors
04/02/2002US6365621 Remedies or preventives for intractable epilepsy
04/02/2002US6365620 Trifluoromethylpyrrolcarboxamides
04/02/2002US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/02/2002US6365564 Asymmetrical imide bleach activators and compositions employing the same
04/02/2002US6365125 Using organotin compound
04/02/2002US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
04/02/2002CA2059610C 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
03/2002
03/28/2002WO2002024692A1 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
03/28/2002WO2002024649A1 Substituted amino-aza-cycloalkanes useful against malaria
03/28/2002WO2002024647A1 Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
03/28/2002WO2002024646A1 Delta1-pyrrolines used as pesticides
03/28/2002WO2002024645A1 Method for producing delta 1-pyrrolines
03/28/2002WO2002024644A1 Delta 1-pyrrolines for use as pesticides
03/28/2002WO2002024643A1 Optically active 2,5-bisaryl-delta1-pyrrolines and their use as pest control agents
03/28/2002WO2002024642A1 Method for producing δ1-pyrrolines
03/28/2002WO2002024636A2 N-acylsulfonamide apoptosis promoters
03/28/2002WO2002024635A2 Aminoalcohol derivatives
03/28/2002WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
03/28/2002WO2002024629A1 Zwitterionic tachykinin receptor antagonists
03/28/2002WO2002024622A1 Method for producing ketocarboxylic acid derivatives
03/28/2002WO2002024613A2 Resorcinol derivatives
03/28/2002WO2002024194A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/28/2002WO2001097751A3 New formulation comprising a betablocker and optionally a cholesterol-lowering agent
03/28/2002WO2001083434A3 P-(sulfonyl)-aryl and heteroaryls amines
03/28/2002WO2001074762A3 Arylsulfates and their use as enhancers or inhibitors of bioadhesion to surfaces
03/28/2002US20020038061 Synthesis of fluorocarbon compounds
03/28/2002US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes
03/28/2002US20020037896 Bicyclic compounds
03/28/2002US20020037856 Novel compounds possessing antibacterial, antifungal or antitumor activity
03/28/2002US20020037574 Recombinant C-proteinase and processes, methods and uses thereof
03/28/2002US20020037534 Combinatorial preparation of a substance library with removal of a zwitterionic compound by precipitation
03/28/2002CA2423356A1 Zwitterionic tachykinin receptor antagonists
03/28/2002CA2423315A1 Substituted amino-aza-cycloalkanes useful against malaria
03/28/2002CA2423262A1 Resorcinol derivatives
03/28/2002CA2422958A1 Optically active 2,5-bisaryl-delta1-pyrrolines and their use as pest control agents
03/28/2002CA2422820A1 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/27/2002EP1191611A2 Piezoelectric element and process for production thereof
03/27/2002EP1189884A1 Removal of contaminants from n-methyl-2-pyrrolidone
03/27/2002EP1189883A2 Substituted pyrrolidines as cell adhesion inhibitors
03/27/2002EP1189882A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
03/27/2002EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation
03/27/2002EP1189612A1 Vla-4 inhibitor compounds
03/27/2002CN1342153A Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in production of medicaments